Loren Data's SAM Daily™

SAMDAILY.US - ISSUE OF JULY 01, 2020 SAM #6789
MODIFICATION

65 -- Medical Countermeasures (MCM) Commercial Solutions Offering (CSO) Area of Interest (AOI) A001 COVID-19 Vaccine Fill and Finish Manufacturing Capacity

Notice Date

6/29/2020 12:46:41 PM
 

Notice Type

Solicitation
 

NAICS

325412 — Pharmaceutical Preparation Manufacturing
 

Contracting Office

W6QK ACC-APG NATICK NATICK MA 01760-5011 USA
 

ZIP Code

01760-5011
 

Solicitation Number

W911QY-20-S-C001-A001
 

Response Due

7/3/2020 3:00:00 PM
 

Archive Date

07/18/2020
 

Point of Contact

Sean G. Auld, Phone: 5082062083, Maria C. Dunton, Phone: 5082062114
 

E-Mail Address

sean.g.auld.civ@mail.mil, maria.c.dunton.civ@mail.mil
(sean.g.auld.civ@mail.mil, maria.c.dunton.civ@mail.mil)
 

Description

Biomedical Advanced Research and Development Authority (BARDA) has a current Area of Interest (AoI) W911QY-20-S-C001-A001 COVID-19 Fill and Finish Manufacturing Capacity to identify and procure US domestic aseptic fill and finish manufacturing capacity for critical vaccines and therapeutics in response to the COVID-19 pandemic to ensure uninterrupted supply throughout the COVID-19 campaign. Identifying and procuring this need is imperative as BARDA-sponsored product developers and manufacturers may not have timely access to this capacity for COVID-19 response. To that end, the government intends to reserve domestic aseptic fill and finish manufacturing capacity for critical vaccines and therapeutics. The reserved capacity shall include unallocated production slots at the specific Contract Manufacturing Organization (CMO) facilities that could be secured for future government use. Included in the �capacity� are the costs associated with facilities and equipment usage for a given production slot, labor, materials as well as support services necessary to fill and release a standard batch fill. The reservation shall exclude the performance of any work within the reserved capacity without explicit, written approval from the government. In accordance with the first AoI Solution Briefs must be submitted no later than 1800 on 3 July, 2020.� See attachment MCM CSO AoI W911QY-20-S-C001-A001 COVID-19 Vaccine Fill Finish for the first area of interest.
 

Web Link

SAM.gov Permalink
(https://beta.sam.gov/opp/cbd037b378a34661b0ddb2a49fb8c02e/view)
 

Place of Performance

Address: Natick, MA 01760, USA

Zip Code: 01760

Country: USA
 

Record

SN05705871-F 20200701/200629230152 (samdaily.us)
 

Source

SAM.gov Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |